EHA 2018 Multiple Myeloma Abstracts ‑ E-Posters
There will be two types of research posters at the 2018 European Hematology Association (EHA) meeting.
The first type is the standard kind of meeting poster, which is put up for display during a poster session so that meeting attendees can view it and speak with one of the poster's authors.
The second type is what has been called "e-posters", or "publication only" posters. These will not be displayed at any time during the meeting. However, meeting attendees will be able to download them from the meeting website and view them.
Listed below are titles and links to the abstracts for the myeloma-related e-posters from the meeting. Most of the posters already have been grouped by the EHA into categories that are myeloma-focused. Other posters are in stem cell transplantation-related and additional categories.
Links to PDF files containing posters will be added to entries in this list as those files are made available to The Beacon courtesy of the EHA presenters.
The Beacon also has a list of the myeloma-related oral presentations that will take place at the 2018 EHA meeting.
In addition, the Beacon has two lists of the myeloma-related poster presentations that will take place at the EHA meeting. There is one list for the posters to be presented on Friday, June 15, and a second list for the posters to be presented on Saturday, June 16.
Infectious Diseases, Supportive Care
PB2049 – Risk Factors Associated To Mortality In Patients With Hemopathies Requiring Entry In The Intensive Care Unit
Estefania Morente Constantin, Ana Beatriz Rivera Gines, Pablo Romero Garcia, Pedro Antonio Gonzalez Sierra, Francisco Manzano Manzano, Almudena Garcia Ruiz, Manuel Jurado Chacon (abstract)
Myeloma and Other Monoclonal Gammopathies – Biology
PB2117 – Detection Of MYD88 L265p Mutation By Digital PCR In Peripheral Blood Samples From IgM Monoclonal Gammopathy Patients
Nieves Garcia-Gisbert, Eugenia Abella, Concepción Fernandez-Rodriguez, Ana Ferrer, Maria del Carmen Vela, Laura Camacho, Xavier Calvo, Sara Montesdeoca, Leonor Arenillas, Eva Gimeno, Carles Besses, Antonio Salar, Beatriz Bellosillo (abstract)
PB2118 – Circulating Tumor DNA Analysis Of KRAS, NRAS And BRAF Mutations Using Mass Spectrometry In Multiple Myeloma Patients
Liang-Tsai Hsiao, Tzeon-Jye Chiou, Jyh-Pyng Gau (abstract)
PB2119 – Mogrol Represents A Novel Anti-myeloma Agent Via ERK And NF-κB Inhibition
Shidai Mu, Lisha Ai, Yu Hu (abstract)
PB2120 – Circulating Exosomal Long Non-Coding RNA PRINS – First Findings In Monoclonal Gammopathies
Dávid Vrábel, Lenka Sedlaříková, Božena Bollová, Lenka Radová, Lucie Brožová, Jiří Jarkovský, Martina Almáši, Miroslav Penka, Petr Kuglík, Viera Sandecká, Martin Štork, Zdeněk Adam, Luděk Pour, Marta Krejčí, Sabina Ševčíková (abstract)
PB2121 – A Role Of Light As Potential Biomarker For Progression Of Smoldering To Symptomatic Multiple Myeloma
Rita Rizzi, Brunetti Giacomina, Anna Mestice, Giuseppina Storlino, Sara Bortolotti, Paola Sindaco, Rosa De Robertis, Paola Curci, Silvia Concetta Colucci, Giorgina Specchia, Maria Grano (abstract)
PB2122 – Differential Mirnome Expression Profile In Non Tumor Lymphomonocytes Of The Peripheral Compartment Of MGUS Subjects
Oriana Bianco, Alessandro Allegra, Manuela Mania, Salvatore Campo, Vanessa Innao, Michele Scuruchi, Doriana Vaddinelli, Angela Avenoso, Angela D'Ascola, Giuseppe Maurizio Campo, Andrea Gaetano Allegra, Caterina Musolino (abstract)
PB2123 – PDCD1, PDL1 And CTLA4 Polymorphisms Associated With The Susceptibility To And Clinical Features Of Multiple Myeloma.
Tetsuhiro Kasamatsu, Maaya Awata, Rei Ishihara, Masumi Ohata, Yukihiro Kanai, Yuki Murakami, Keisuke Murata, Saki Watanabe, Noriyuki Takahashi, Nanami Gotoh, Makiko Takizawa, Akihiko Yokohama, Norifumi Tsukamoto, Hiroshi Handa, Takayuki Saitoh, Hirokazu Murakami (abstract)
PB2124 – Novel Therapeutics For Multiple Myeloma Tested In A 3d Bone Marrow Model
Maaike Braham, Anil Deshantri, Monique Minnema, Zsolt Sebestyen, Trudy Straetemans, Jurgen Kuball, Cumhur Öner, Raymond Schiffelers, Marcel Fens, Jacqueline Alblas (abstract)
PB2125 – Features Of Stromal Bone Marrow Microenvironment In Patients With Multiple Myeloma With Ineffective Transplantation Of Peripheral Hematopoietic Stem Cells
Natalya Semenova, I.I. Kostroma, S.V. Gritsaev, S.S. Bessmeltsev, V.I. Rugal (abstract)
PB2126 – Myeloma Cell Death Induced By Zebularine Leads To cMyc Downregulation And Is Decreased By Cytidine Deaminase Overexpression.
Patryk Krzeminski, Ramón García-Sanz, Norma Gutiérrez (abstract)
PB2127 – Podocyturia In Multiple Myeloma Patients Has A Tendency To Increase With Treatment
Tolga Kuzu, Saime Paydaş, Emel Gurkan, Semra Paydas, Aysun Hatice Uğuz (abstract)
PB2128 – Human Monoclonal IgG Derived From Patients With Multiple Myeloma Are Able To Penetrate Living Neoplastic Cells And Exhibit Intracellular Biological Functions
Ioannis Sarrigeorgiou, Evangelos Terpos, Theodora Stivarou, Petros Chalas, Efstathios Kastritis, Meletios A. Dimopoulos, Peggy Lymberi (abstract)
PB2129 – High-Risk Young Multiple Myeloma Patients Treated Up-Front With Lenalidomide: Impact Of KIR3DL1-edu And KIR Haplotypes On Clinical Outcome
Fabrizio Puglisi, Alessandra Romano, Concetta Conticello, Sebastiana Toscano, Maria Pia Azzaro, Marina Parisi, Valeria Calafiore, Enrica Martino, Giuseppe Sapienza, Salvatore Leotta, Giuseppe Milone, Grazia Sortino, Francesco Di Raimondo (abstract)
PB2130 – The Involvement Of Mesangiogenic Progenitor Cells In Multiple Myeloma Pathogenesis
Claudia Pia Schifone, Simone Pacini, Marina Montali, Serena Barachini, Francesca Margherita Panvini, Gabriele Buda, Francesco Mazziotta, Francesca Martini, Mario Petrini (abstract)
PB2131 – Myeloid And Lymphoid Dendritic Cells In Patients With Monoclonal Gammopathy Of Undetermined Significance - Possible Link With Disease Progression
Ewelina Grywalska, Marcin Pasiarski, Agnieszka Stelmach-Goldys, Barbara Sosnowska-Pasiarska, Pawel Steckiewicz, Anna Kowalska, Krzysztof Gosik, Bartosz Garus, Stanislaw Gozdz, Jacek Rolinski (abstract)
PB2132 – Quantification And Characterization Of Bone Marrow Mesenchymal Stromal Cells In Monoclonal Gammopathies
Rui Leite, João Barradas, Bruno Paiva, Isabel Silva, Paula Rocha, Helena Silva, Catarina Geraldes, Artur Paiva (abstract)
PB2133 – Analyzing Bone And Extramedullary Plasmacytoma Substrates In Patients With Multiple Myeloma
Maiia Firsova, Larisa Mendeleeva, Alla Kovrigina, Natalia Deineko, Maxim Solovev, Valeri Savchenko (abstract)
PB2134 – Association Of HLA-Specificities Of Classes I, II With Immunochemical Variants Of Multiple Myeloma
Elena Poponina, Elena Butina, Galina Zaytseva, Natalia Minaeva, Igor Paramonov (abstract)
PB2135 – Reconsidering JAK2 In An Inter-Tumour Heterogeneity Of Multiple Myeloma
Suchada Sommaluan, Budsaba Rerkamnuaychoke, Teeraya Puavilai, Suporn Chuncharunee, Takol Chareonsirisuthigul, Pitichai Pornsarayuth, Teerapong Siriboonpiputtana (abstract)
PB2136 – Targeting Siglec-7: A Novel Immunotherapeutic Approach To Potentiate The Cytotoxic Functions Of Natural Killer Cells Against Multiple Myeloma
John Daly, Subhashis Sarkar, Alessandro Natoni, Jinsong Hu, Sachin Chauhan, Robert Henderson, Tony Duggan, Lucy Kirkham, Cian McEllistrim, Michael O'Dwyer (abstract)
PB2137 – Bone Marrow Mesenchymal Stromal Cells From Healthy Donors Secrete Anti-angiogenic Extracellular Vesicles As Well As Soluble Factors Having Growth Inhibitory Effect In Multiple Myeloma
Tomohiro Umezu, Satoshi Imanishi, Nina Gladkova, Kazuma Ohyashiki, Junko Ohyashiki (abstract)
PB2138 – Impact Of The Expression Of LRP Gene On The Sensitivity Of Tumor Plasma Cells To Bortezomib In Vivo And In Vitro
Yulia Chernykh, Anatoliy Golenkov, Ekaterina Rybalkina, Sain Shushanov, Tatiana Mitina, Elena Kataeva, Elena Trifonova, Elena Klinushkina, Sergey Zakharov, Lyudmila Vysotskaya, Kirill Belousov (abstract)
PB2139 – Effect Of Autologous Stem Cells Transplantation Of Patients With Multiple Myeloma On The Calorimetric Markers Of The Serum Proteome. Correlation With The Immunological Markers
Lidia Gartcheva, Avgustina Danailova, Svetla Todinova, Keranka Dimitrova, Vileta Petkova, Sashka Krumova, Margarita Guenova Guenova, Stefka Taneva, Branimir Spassov (abstract)
PB2140 – Study Of Multiple Myeloma Chromosomal Abnormalities By Multiplex Ligation-Dependent Probe Amplification: Correlations With Fluorescence In Situ Hybridization
Flavia Carbone, Filomena Nozza, Gabriella Vona, Alessandra Dell'Acqua, Scarciolla Oronzo, Clara Mannarella, Angela Ciancio, Bruna Daraia, Giuseppe Pietrantuono, Imma Attolico, Roberta Nuccorini, Sara Pascale, Pellegrino Musto, Michele Pizzuti, Alberto Fragasso (abstract)
PB2141 – Activin A: A Novel Urinary Biomarker Reflecting Early Renal Impairment In Multiple Myeloma
Hirono Iriuchishima, Akito Maeshima, Shunsuke Takahashi, Takuma Ishizaki, Akihiko Yokohama, Norifumi Tsukamoto, Takayuki Saitoh, Hirokazu Murakami, Hiroshi Handa (abstract)
PB2142 – Raman Spectroscopy Is Able To Discriminate Between CD138- / CD138+ Plasma Cells Of Multiple Myeloma Patients
Alessandro Allegra, Oriana Bianco, Enza Fazio, Martina Bonsignore, Fortunato Neri, Guido Ferlazzo, Sebastiano Trusso, Domenico Franco, Laura M. De Plano, Maria Giovanna Rizzo, S. Crea, Salvatore Pietro Paolo Guglielmino, Caterina Musolino (abstract)
PB2143 – PDGFR-Β And CXCR4 In Multiple Myeloma Disease Stages: Preliminary Results
Leonor Correia, Maria Margarida Tenreiro, Margarida Silveira, Maria Alexandra Brito, Rui Malhó (abstract)
PB2144 – Introduction Of A European Quality Assessment Scheme For Genetic Testing In Myeloma: Progress And Update.
Polly Talley, Andrew Chantry, Angela Cox, Katrina Rack, Rosalind Hastings (abstract)
PB2146 – Molecular Cytogenetic Analysis In Multiple Myeloma / Plasma Cell Leukemia Patients With Circulating Plasma Cells
Jana Balcárková, Miroslava Mlynárčiková, Jiří Minařík, Tomáš Pika, Petra Krhovská, Helena Urbánková, Tomáš Papajík (abstract)
PB2147 – Altered MicroRNA Expression Profile In The Peripheral Lymphomonocytes Of Multiple Myeloma Patients With Bisphosphonate-Induced Osteonecrosis Of The Jaw.
Vanessa Innao, Alessandro Allegra, Giacomo Oteri, Manuela Mania, Angela D'Ascola, Oriana Bianco, Angela Avenoso, Doriana Vaddinelli, Andrea Gaetano Allegra, Salvatore Campo, Caterina Musolino (abstract)
PB2148 – Relationship Of Molecular Peculiarities With Cytogenetic Aberrations In Multiple Myeloma
Elena Nazarova, Maria Sarpova, Natalija Minaeva, Jemilija Suhorukova, Igor Paramonov, Ekaterina Zotina, Irina Dokshina, Victor Shardakov (abstract)
PB2149 – Epidemiology Of Multiple Myeloma In A Large Metropolitan Area Of Russia (Novosibirsk)
Natalia Skvortsova, Tatiana Pospelova, Igor Kovynev (abstract)
PB2150 – The Molecular Signatures Of High Risk Multiple Myeloma In Thai Population
Parin Kamseng, Teerapong Siriboonpiputtana, Teeraya Puavilai, Karan Paisooksantivatana, Takol Chareonsirisuthigul, Suporn Chuncharunee, Budsaba Rerkamnuaychoke (abstract)
PB2151 – The Novel Translocation Of T(1;21) In Multiple Myeloma With Complex Karyotype
Mufide Okay, Rafiye Ciftciler, Elifcan aladag, Hakan Goker (abstract)
Myeloma and Other Monoclonal Gammopathies – Clinical
PB2153 – Real-World Evidence Of The Use Of Carfilzomib Among Patients With Relapsed Multiple Myeloma In Europe: An Interim Analysis From A Prospective Observational Study
Evangelos Terpos, Jo Caers, Maaike Sohne, Florence Suzan, Marieke Schoonen, Sally Wetten, Cheryl Turkington, Marco Ladetto, Daniel Lechner (abstract)
PB2154 – Assessment Of Pneumococcal Vaccination Response In Multiple Myeloma
Marc Ellis, Naomi Runnegar, Patrick Hogan, Peter Mollee (abstract)
PB2155 – Pomalidomide Plus Dexamethasone (Pd) In The Treatment Of Asian Patients With Relapsed / Refractory Myeloma (RRMM) Who Are Previously Refractory To Lenalidomide – A Trial By The Asian Myeloma Network (AMN)
Wj Chng, Kihyun Kim, Shang yi Huang, Chor-Sang Chim, Naoki Takezako, Hideki Asaoku, Hideo Kimura, Hiroshi Kosugi, Junichi Sakamoto, Sathish Gopalakrishnan, Yuan Wei, Shu Ling Lee, Jejung Lee, Sung Soo Yoon, Jin-Seok Kim, Chang-Ki Min, Jae-Hoon Lee, Brian Durie (abstract)
PB2156 – Evaluation Of Pulmonary Function Tests In Patients With Myeloma Reveals That Pulmonary Abnormalities Are Common And Are Independently Associated With Worse Outcome
Efstathios Kastritis, Despina Fotiou, Georgia Trakada, Maria Gavriatopoulou, Ioannis Panagiotidis, Dimitrios C. Ziogas, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Lemonia Velentza, Anastasios Kallianos, Evangelos Terpos, Meletios A. Dimopoulos (abstract)
PB2157 – Early Paraprotein Reduction And Response To First-Line Treatment In Multiple Myeloma
Moritz Binder, S. Vincent Rajkumar, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Angela Dispenzieri, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Suzanne R. Hayman, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, Shaji K. Kumar (abstract)
PB2158 – Characterization And Treatment Outcome Of IgE Multiple Myeloma – A Case Series.
Artur Jurczyszyn, Jorge J. Castillo, David H. Vesole, Jieqi Liu, Irit Avivi, Anna Waszczuk-Gajda, Ewa Lech-Maranda, Massimo Gentile, Gabor Mikala, Thomas Guerrero-Garcia, Anna Suska, Morie A. Gertz (abstract)
PB2159 – Good Outcomes Using Active Treatment With Novel Agents In Elderly Myeloma Patients
Nadishani Ediriwickrama, Titilola Oyebamiji, Sreetharan Munisamy, Stella Bowcock (abstract)
PB2160 – Montelukast Combined With The Lipid Lowering Drug Gemfibrozil Reverses Resistance To Combination Chemotherapy In Patients With Multiple Myeloma. Results Of Prospective Phase 1 / 2 Clinical Trial
Stephen O'mara (abstract)
PB2161 – Autologous Transplantation With Reduced Pre-Transplant Conditioning In Patients With Multiple Myeloma At A Higher Age – Toxicity Versus Efficacy.
Alexandra Jungova, Eva Havlova, Tereza Zabranska, Daniel Lysak, Pavel Jindra (abstract)
PB2162 – The Prospective Intersectoral National Cohort Study MYRIAM To Study Characteristics, Treatment And Outcome Of Patients With Multiple Myeloma In Germany
Wolfgang Knauf, Monika Engelhardt, Christoph Losem, Jörg Lipke, Christian Kasper, Leonora Houet, Corinne Vannier, Martina Jänicke, Norbert Marschner, Tobias Dechow, Hermann Einsele (abstract)
PB2164 – First-Line Therapy With Bendamustine / Prednisone / Bortezomib (BPV) For Non-Transplant Eligible Symptomatic Multiple Myeloma Patients
Wolfgang Knauf, Gerrit Dingeldein, Rudolf Schlag, Manfred Welslau, Christina Kunz, Thomas Moehler, Christina Habermehl, Hartmut Goldschmidt, Marc S. Raab, Trial Group BPV (abstract)
PB2165 – Lenalidomide Maintenance Chemotherapy; An Analysis Of Real World Survival Data In Multiple Myeloma Patients Treated With Autologous Stem Cell Transplant And Bortezomib-Based Induction
Hannah Cherniawsky, Irwin Sandhu, Michael Chu, Joanne Hewitt, Ismail Ismail, Andrew Belch, Linda Pilarski, Tatiana Nikitina, Christopher Venner (abstract)
PB2166 – Carfilzomib And Dexamethasone Versus 8 Cycles Of Bortezomib And Dexamethasone: An Indirect Comparison And Exploratory Analysis Of The Efficacy And Safety Of The Randomized, Phase 3 ENDEAVOR Trial
Katja Weisel, Istvan Majer, Lucy DeCosta, Albert Oriol, Hartmut Goldschmidt, Heinz Ludwig, Marco Campioni, Zsolt Szabo, Meletios Dimopoulos (abstract)
PB2167 – MYC Rearrangement In Cohort Of Newly Diagnosed Slovenian MM Patients
Helena Podgornik, Nika Zima, Judita Nussdorfer, Hermina Čibej, Ana Doplihar Kebe, Samo Zver (abstract)
PB2168 – Supervised And Home-Based Exercise In Patients Newly Diagnosed With Multiple Myeloma – A Randomized Controlled Feasibility Study
Rikke Faebo Larsen, Mary Jarden, Lisbeth Rosenbek Minet, Ulf Christian Frølund, Niels Abildgaard (abstract)
PB2169 – Detection Of Asymptomatic Femoral Head Avascular Necrosis On Routine Whole Body MRI In Patients With Multiple Myeloma Provides Opportunities For Joint Preservation.
Priya Sriskandarajah, Naeem Ahmed, Christian Burd, Vallari Shah, Angela Riddell, Kevin Boyd, Martin Kaiser, Christina Messiou (abstract)
PB2170 – Association Of Clinical Response With Survival And Quality Of Life (QoL) After Carfilzomib And Dexamethasone (Kd56) Treatment In The Phase 3 ENDEAVOR Trial
David Siegel, Heinz Ludwig, Philippe Moreau, Maria-Victoria Mateos, Ruben Niesvizky, Wee Joo Chng, Khalid Mezzi, Zhao Yang, Sumeet Panjabi, Meletios Dimopoulos (abstract)
PB2171 – Effect Of Compound Kushen Injection On Immune Function For Patients With Newly Diagnosed Multiple Myeloma Undergoing Chemotherapy
Honglei Tu, Lingling Zhang, Lu Ding, Yanxia Jin, Fuling Zhou (abstract)
PB2172 – Analytical Criticalities Associated To Different Methods For Serum Free Light Chain Detection: Impact On The International Myeloma Working Group (IMWG) Criteria Defining Symptomatic Multiple Myeloma
Katja Weisel, Hans Salwender, Monika Ums, Lothar Kanz, Reinhild Klein, Andreas Peter (abstract)
PB2173 – Eligibility Criteria For Clinical Trials And Comorbidity As Predictors Of Chemotherapy Dose Adjustment In Patients With Multiple Myeloma
Ernesto Pérez Persona, Ariane Unamunzaga, Itziar Oiartzabal Ormategui, Ana Vega Gonzalez de Viñaspre, Rosana Diez Angulo, Ana Santamaría Lopez, Laida Cuevas Palomares, Carlos de Miguel Sanchez, Diego Robles de Castro, Angel Pereda Vicandi, Miren Gabilondo Jalon, Jose María Guinea de Castro (abstract)
PB2174 – A Comparative Analysis Of Free Light Chain Concentrations In Serum And Cerebrospinal Fluid For Patients With Multiple Myeloma Complicated By Myeloradiculopathy
Елена Трифонова, Анатолий Голенков, Татьяна Митина, Оксана Москалец, Иветта Когарко, Кирилл Белоусов, Елена Катаева, Андрей Кедров (abstract)
PB2175 – The Clinical Significance Of The Immunophenotypic Profile Of Tumor Plasma Cells In The Bone Marrow And Peripheral Blood In Multiple Myeloma Complicated By Plasmacytomas.
Kirill Belousov, Татьяна Митина, Юлия Чуксина, Анатолий Голенков, Елена Трифонова, Елена Катаева, Юлия Черных, Людмила Высоцкая, Сергей Захаров, Елена Клинушкина, Александр Митин, Александр Караулов (abstract)
PB2176 – The Occurrence And Economic Burden Of Treatment-Induced Peripheral Neuropathy In Patients With Multiple Myeloma In Sweden
Hareth Nahi, Göran Walinder, Francesca Gatta, Heval Beydogan, Aaron Levine, Cecilia Lourdudoss, Istvan Majer, Sebastian Gonzalez-McQuire, Markus Hansson (abstract)
PB2177 – Outcomes Of Treatment Of Multiple Myeloma In Patients Requiring Renal Replacement Therapy: “Real World” Single Centre Experience Over An 11 Year Period
Aruni Ratnayake, Mukunthan Srikantharajah, David Makanjuola, Simon Stern (abstract)
PB2178 – Prognostic Role Of Neutrophil-Lymphocyte Ratio In Patients With Multiple Myeloma
Alexander Luchinin, Natalia Minaeva, Sergey Semochkin (abstract)
PB2179 – Bleeding And Thrombotic Complications In Plasma Cell Disorders In The "Novel Agents Era": Risk Factors, Outcome, Progression And Strategies Of Prevention. A Real-life Monocentric Retrospective Analysis
Lorenza Torti, Anna Maria Morelli, Francesco Bacci, Paolo Di Bartolomeo (abstract)
PB2180 – Multiple Myeloma And Infections In The “Novel Agents Era”: A Real-life Retrospective Unicentric Experience.
Maria Stefania Infante, Isabel Gonzalez, Carolina Muñoz, Maria Angeles Foncillas, Cecilia Heras, Karen Marin, Jose Angel Hernandez-Rivas (abstract)
PB2181 – Outcome Of Relapsed Or Refractory Multiple Myeloma Patients Treated With PCcd (Pomalidomide - Cyclophosphamide-Clarithromycin - Low-Dose Dexamethasone) In The Real-life Setting
Rafael Ríos-Tamayo, Agustín Martín, Dolores Sánchez-Rodríguez, María Esther Clavero, Ana Beatriz Rivera, Teresa Rodríguez, María José Olivares, Rocío Sánchez, Carolina Alarcón, Alberto Jiménez, Jon Badiola, Estefanía Morente, Pilar Garrido, Juan Sainz, Manuel Jurado (abstract)
PB2182 – Survival Of Relapsed Myeloma Patients With A Second Autograft: Local Experience
Craig Hendry, Richard Soutar (abstract)
PB2183 – Norwegian Real-Life Experience Of Preapproval Carfilzomib Through Compassionate Use Named Patient Program (NPP) For Relapsing / Refractory Myeloma (RRMM)
Ina Haarstad, Anna Lysén, Fredrik Schjesvold (abstract)
PB2184 – Phase III (IKEMA) Study Design: Isatuximab Plus Carfilzomib And Dexamethasone (Kd) Vs Kd In Patients With Relapsed / Refractory Multiple Myeloma (RRMM).
Philippe Moreau, Meletios-Athanassios Dimopoulos, Kwee Yong, Joseph Mikhael, Marie-Laure Risse, Gaëlle Asset, Thomas Martin (abstract)
PB2185 – Phase III (IMROZ) Study Design: Isatuximab Plus Bortezomib, Lenalidomide, And Dexamethasone (VRd) Versus VRd In Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma.
Thierry Facon, Hartmut Goldschmidt, Michele Cavo, Thomas Martin, Gautier Paux, Corina Oprea, Robert Orlowski (abstract)
PB2186 – A Multi-Center Retrospective Study Of Bone Destruction Associated With 419 Newly Diagnosed Multiple Myeloma
Yanxia Jin, Hailing Liu, Lu Ding, Xiqin Tong, Honglei Tu, Pan Liu, Hui Shen, Fuling Zhou (abstract)
PB2187 – Montelukast And Gemfibrozil When Added To Bortezomib Based Therapy Induces Rapid Response In Patients With Refractory And High Risk Disease.
Stephen O'mara (abstract)
PB2188 – Efficacy, Safety And Tolerability Of Carfilzomib-Lenalidomide-Dexamethasone (KRd) Regimen In RRMM
Valeria Calafiore, Enrica Martino, Marina Parisi, Giuseppe Sapienza, Vittorio Del Fabro, Salvatore Leotta, Alessandra Romano, Concetta Conticello, Francesco Di Raimondo (abstract)
PB2189 – Autologous Stem Cell Transplant In Patients With Multiple Myeloma And Renal Failure
Lauren Foster, Swabirah Rassool, Yonghan Li, Fiona Dignan, David Osborne, Jane Norman, Clare Barnes, Rachel Brown, Chiara Lobetti-Bodoni, Suzanne Roberts, Chris Gregory, Rachel Beezley, Marie Waller, Satarupa Choudhuri, Hassan Osman, Esraa Abu-Rashed, Shinod Raj, Rowena Thomas-Dewing, Martin Rowlands, Katie Brice, Jaya Sudhir, Eleni Tholouli, Alberto Rocci (abstract)
PB2190 – KRD Treatment Of Relapsed / Refractory Multiple Myeloma Patients: A Real Life Experience
Gregorio Barilà, Vittorio Meneghini, Angela Bonalumi, Anna Furlan, Francesca Patriarca, Fabrizia Colasante, Francesca Scognamiglio, Roberto Sartori, Maurizio Rupolo, Martina Tinelli, Norbert Pescosta, Claudia Minotto, Albana Liço, Tamara Berno, Gianpietro Semenzato, Renato Zambello (abstract)
PB2191 – Oral Cyclophosphamide’s Addition In Relapsed / Refractory Multiple Myeloma Patients With Biochemical Progression During Lenalidomide-Dexamethasone Treatment
Laura Cesini, Agostina Siniscalchi, Sara Grammatico, Alessandro Andriani, Alessia Fiorini, Luca De Rosa, Tommaso Za, Angela Rago, Tommaso Caravita, Maria Teresa Petrucci (abstract)
PB2192 – Early Relapse After Autologous Bone Marrow Transplantation Is A Major Predictive Factor Of Lower Overall Survival In Multiple Myeloma Patients
Adriana Roque, Maria Carolina Afonso, Emília Cortesão, Ana Isabel Espadana, Ana Bela Sarmento-Ribeiro, Catarina Geraldes, Maria Letícia Ribeiro (abstract)
PB2195 – Light-Chain Deposition Disease: Diagnosis And Treatment Challenges. A Single Center Experience
Sorina Badelita, Andreea Jercan, Ruxandra Irimia, Monica Popescu, Didona Vasilache, Camelia Pantoc, Daniel Coriu (abstract)
PB2197 – Factors Associated With Renal Failure And Renal Function Recovery In Multiple Myeloma
Aysun Senturk Yikilmaz, Şule Mine Bakanay, Sema Akinci, Mehmet Gündüz, Selin Küçükyurt Kaya, Servihan Doğan, İmdat Dilek (abstract)
PB2198 – Degree Of Vulnerability In Patients With Multiple Myeloma: A Comparative Study Between The Application Of Clinical Judgment And The Scale Of Assessment (GA Scale)
Eugenia Abella, Francesc García-Pallarols, Randa Ben Lashen, Alicia Senín, Laia Martinez-Serra, Sara Montesdeoca, Ivonne Párraga, Elena Torres, David Román, Mariana Ferraro, Anna Angona, Carles Besses (abstract)
PB2199 – Impact Of Improvement In Renal Function And Waiting Time Before Induction Therapy On Survival In Newly Diagnosed Multiple Myeloma
Nikolett Wohner, Gergely Varga, Peter Farkas, Laura Horvath, Gergely Szombath, Eszter Horvath, Alexandra Balogh, Andras Masszi, Judit Varkonyi, Tamas Masszi (abstract)
PB2201 – Comparing Efficacy Of Initial Induction In Newly Diagnosed Multiple Myeloma. A Valuable Information In Population-Based Registries
Rafael Ríos-Tamayo, María José Sánchez Pérez, Dolores Sánchez-Rodríguez, Agustín Martín García, Yoe-Ling Chang-Chan, Sergio Sequera, José Luís García de Veas Silva, Juan Sainz Pérez, Ana Beatriz Rivera Ginés, María Esther Clavero Sánchez, Carolina Alarcón Payer, Manuel Jurado Chacón (abstract)
PB2202 – Efficacy Of New Drugs Prior To Single Or Tandem Autologous Stem Cell Transplantation In Newly Diagnosed Multiple Myeloma Patients. A Single Center Experience
Sara Grammatico, Elisabetta Lisi, Federico Vozella, Laura Cesini, Alfonso Piciocchi, Saveria Capria, Robin Foà, Maria Teresa Petrucci (abstract)
PB2203 – Bendamustine-Bortezomib-Dexamethasone (BVD) In Heavily Pretreated Multiple Myeloma
Claudio Cerchione, Lucio Catalano, Davide Nappi, Anna Emanuele Pareto, Santina Basile, Luana Marano, Ilaria Peluso, Luigia Simeone, Orsola Vitagliano, Salvatore Palmieri, Stefano Rocco, Giuseppe Monaco, Alessandra Romano, Fabrizio Pane, Felicetto Ferrara (abstract)
PB2204 – Efficacy Of Retreatment With Immunomodulatory Drugs And Proteasome Inhibitors Following Daratumumab Monotherapy In Relapsed And Refractory Multiple Myeloma Patients
Rimke Oostvogels, Margot Jak, Reinier Raijmakers, Rogier Mous, Monique Minnema (abstract)
PB2205 – The Effect Of Surgical Intervention In The Treatment Of Solitary Plasmacytoma Of The Bone
Marvyn T. Koning, Iris Noordhoek, Peter A. von dem Borne, Laurien A. Daniëls, Willem Pondaag, Arjen H.G. Cleven, Hendrik Veelken, Sander Dijkstra (abstract)
PB2206 – Uninvolved IgA Suppression Predicts Evolution To Symptomatic Myeloma In Contemporary Diagnosed SMM; Preliminary Results
Paraskevi Papaioannou, A.I. Gkioka, K. Tsalimalma, A. Koudouna, S. Kotsanti, K. Bitsani, D. Maltezas, T. Iliakis, M. Dimou, Ν. Kafassi, P. Sfikakis, P. Panayiotidis, M.C. Kyrtsonis (abstract)
PB2207 – Comparison Of Two Mobilization Regimens For Newly Diagnosed Multiple Myeloma Patients
Elena Mariggiò, Laura Lombardi, Federico Vozella, Francesca Fazio, Alfonso Piciocchi, Robin Foà, Maria Teresa Petrucci (abstract)
PB2208 – Impact Of Novel Agents On Aggressive Relapse Of Multiple Myeloma: A Single Center Experience
Enrica Martino, Valeria Calafiore, Marina Silvia Parisi, Vittorio Del Fabro, Giuseppe Sapienza, Alessandra Romano, Concetta Conticello, Francesco Di Raimondo (abstract)
PB2209 – Real World Data Of Age Related Cytogenetic Abnormality Distribution In Multiple Myeloma Patients At Diagnosis: Single Centre Experience From The United Kingdom
Jennifer Tam, Rajesh Krishna, Karen Marshall, Lara Cresswell, Catherine Morrow, Linda Barton, Graham Asagba, Mamta Garg (abstract)
PB2211 – High Implementation Adherence To Lenalidomide In Multiple Myeloma
Irina Amitai, Hila Magen, Alon Rozenthal, Sabina De Geest, Eric Tousset, Iuliana Vaxman, Pia Raanani, Arnon Nagler, Avi Leader (abstract)
PB2212 – Long Term Disease Control With Pomalidomide And Dexamethasone In Relapsed / Refractory Multiple Myeloma Patients: A Real Life Experience
Marina Silvia Parisi, Valeria Calafiore, Enrica Martino, Salvatore Leotta, Maria Cristina Pirosa, Giuseppe Sapienza, Vittorio Del Fabro, Alessandra Romano, Concetta Conticello, Francesco Di Raimondo (abstract)
PB2213 – The Determination Of Factors Affecting On The Progression-Free Survival Of Multiple Myeloma Patients
Andrei Garifullin, Sergey Voloshin, Alexey Kuvshinov, Anastasiya Kuzyaeva, Alexander Sсhmidt, Zhanna Chubukina, Vasiliy Shuvaev, Evgeniy Krasnikov, Stanislav Bessmeltsev (abstract)
PB2214 – Phase 2 Study For Carfilzomib Plus Elotuzumab Plus Dexamethasone For Myeloma Patients Relapsed After 1-3 Prior Treatment Lines
Raija Silvennoinen, Hareth Nahi, Pekka Anttila, Perttu Koskenvesa, Juha Lievonen, Sini Luoma, Anu Räsänen, Ville Varmavuo, Anu Sikiö, Marita Nurmi, Marjaana Säily, Marja Sankelo, Esa Jantunen, Tarja-Terttu Pelliniemi, Sorella Ilveskero, Muntasir Mamum Majumder, Caroline Heckman (abstract)
PB2215 – The Treatment With Pegylated Liposomal Doxorubicin, Cyclophosphamide And Dexamethasone (CED) For Relapsed And Refractory Multiple Myeloma
Mihai Ionita, Ioana Ionita, Florica Ghilezan, Despina Calamar, Violeta Todorescu, Claudiu Ionita, Dacian Oros, Cristina Sorica, Hortensia Ionita (abstract)
PB2216 – Clinical Features And Outcomes Of Solitary Plasmacytomas: Single-Center Experience From Turkey
Yusuf Ulusoy, Eren Arslan Davulcu, Fahri Sahin, Nur Soyer, Emine Serra Kamer, Nazan Ozsan, Mine Hekimgil, Guray Saydam (abstract)
PB2217 – Bortezomib-Cyclophosphamide-Dexamethasone Induction Therapy Is Comparable To Bortezomib-Thalidomide-Dexamethasone In Newly Diagnosed Myeloma: A Single Centre Experience
Firas Al-Kaisi, D Smith, FR Wadelin, E Das-Gupta, S Henshaw, S Adams, CD Williams (abstract)
PB2218 – Retrospective Audit Of Bisphosphonate Use In Multiple Myeloma Patients In Two District General Hospitals And Fracture Consensus
Zahbia Saleem, Rebecca Allam, Tracy Hui, Anna Bebb, Akila Danga, Taku Sugai (abstract)
PB2219 – Prognostic Significance Of The Chromosome 1 Abnormalities In Patients With Multiple Myeloma
Jelena Bila, Vladislava Djurasinovic, Aleksandra Sretenovic, Jelena Jelicic, Marija Dencic Fekete, Maja Perunicic Jovanovic, Darko Antic, Biljana Mihaljevic (abstract)
PB2220 – Prognostic Significance Of The Revised International Staging System In Transplant-Eligible Patients With Multiple Myeloma
Jelena Bila, Milena Todorovic Balint, Darko Antic, Vladislava Djurasinovic, Aleksandra Sretenovic, Jelena Jelicic, Marija Dencic Fekete, Maja Perunicic Jovanovic, Biljana Mihaljevic (abstract)
PB2221 – Effect Of Bisphosphonate And Anti-Myeloma Therapy On Bone Turnover Markers In Multiple Myeloma
Aditya Jandial, Sachin H J, Kundan Mishra, Sanjay Bhadada, Ashwani Sood, Deepesh Lad, Ritu Aggarwal, Mahesh Prakash, Gaurav Prakash, Vikas Suri, Alka Khadwal, Savita Kumari, Neelam Varma, Pankaj Malhotra (abstract)
PB2223 – Carfilzomib-Lenalidomide-Dexamethasone In The Management Of Lenalidomide-Refractory Multiple Myeloma
Claudio Cerchione, Katia Ferrara, Ilaria Peluso, Maria Di Perna, Irene Zacheo, Davide Nappi, Anna Emanuele Pareto, Alessandra Romano, Fabrizio Pane, Lucio Catalano (abstract)
PB2224 – Frequency And Causes Of Not Receiving Successive Lines Of Treatment In Refractory Multiple Myeloma: A Cross-Sectional Study.
Alicia Senín, Francesc García-Pallarols, Randa Ben Lashen, Laia Martínez-Serra, Sara Montesdeoca, David Román, Mariana Ferraro, Ivonne Párraga, Carlos Besses, Eugenia Abella (abstract)
PB2225 – Autologous Stem Cell Transplantation In Newly Diagnosed Elderly Multiple Myeloma Patients: A Single Centre Experience
Tamara Berno, Marcello Riva, Lucia Ammirati, Andrea Visentin, Carmela Gurrieri, Antonio Branca, Lucia Checuz, Albana Lico, Gregorio Barilà, Matteo Leoncin, Silvia Imbergamo, Francesco Piazza, Livio Trentin, Gianpietro Semenzato, Renato Zambello (abstract)
PB2226 – Incorporation Of Technology In Our Multiple Myeloma Consultation: A Year Of Experience
José María Sánchez-Raga, Ana Ortuño-Cabrero, Albert Pérez-Montaña, Neus Beltran, Teresa Ros, Bernardo López-Andrade, Maria del Carmen Ballester-Ruiz, Laura Lo Riso, Leyre Bento, Lucía García-Maño, Maria Antonia Duran, Antonia Sampol-Mayol (abstract)
PB2227 – Treatment With Ixazomib In Heavily Pretreated Patients With Multiple Myeloma In Slovenia: Real Life Data
Ana Čebokli, Nika Zima, Samo Zver (abstract)
PB2228 – Service Delivery Of Approved Daratumumab Treatment For Relapsed Myeloma; Challenges Of Normal Immunoglobulin And Unaffected Free Light Chain Suppression, Especially When ASCT Is Included.
Ray Powles, Linda Little, Joanna Sheldon, Rachel Wheeler (abstract)
PB2230 – Does Asymptomatic D-dimer Elevation Predict Thrombosis In Patients On Immunomodulatory Drugs In Multiple Myeloma: Real-Life Data
Mürüvvet Seda Aydın, Satı Coskun Yazgan, Elifcan Karakulak, Rafiye Çiftçiler, Engin Kelkitli, Mehmet Turgut, Hakan Goker, Haluk Demiroglu, Osman Ozcebe, Ibrahim Haznedaroglu, Salih Aksu, Fatma Tekin (abstract)
PB2231 – Renal Salvage With Bortezomib / Cyclophosphamide / Dexamethasone Induction Therapy In Newly Diagnosed Multiple Myeloma Patients With Renal Insufficiency: A Single-Center Study From North India
Uttam Nath, Rituparna Chetia, Jayanta Nanda, Avriti Baveja (abstract)
PB2232 – Clinical Efficacy And Safety Of Lenalidomide In NHS Greater Glasgow & Clyde
Louis Doherty, Richard Soutar, Katie MacLure (abstract)
PB2233 – Minimal Residual Disease Negativity After Molecularly Targeted Venetoclax Therapy Of Secondary Plasma Cell Leukemia With Translocation T(11;14)
Gabor Mikala, Andrea Cegledi, Otto Csacsovszki, Monika Peto, Zsuzsanna Szemlaky, Miklos Udvardy, Szabolcs Tasnady, Andras Kozma, Peter Remenyi, Istvan Valyi-Nagy (abstract)
PB2234 – Salvage Therapy With Pomalidomide-Based Regimen In Relapsed / Refractory Myeloma. Efficacy, And Safety Results.
Maialen Sirvent Auzmendi, Susana Herraez Rodriguez, Ernesto Perez Persona, Nerea Caminos Altuna, Iratxe Urreta Barallobre, Esther Perez Santaolalla, Izaskun Ceberio Echechipia, Maria Araiz Ramirez (abstract)
PB2235 – Risk Factors For Early Mortality In Multiple Myeloma With Different Survival Time Cut-Off Points: Real-Life Data
Mürüvvet Seda Aydın, Elifcan Karakulak, Rafiye Çiftçiler, Haluk Demiroğlu, Hakan Goker, Mehmet Turgut, Engin Kelkitli, Nilgun Sayinalp, Yahya Buyukasik, Fatma Tekin (abstract)
PB2237 – Maintenance Treatment With Thalidomide After Frontline Bortezomib-Based Regimens In Transplantation Ineligible Patients With Myeloma Multiple (MM). Experience Of Real Life
Dunia De Miguel Llorente, Angela Gil, Helga Guillen, Alejandro Vazquez, Nuria Golbano, Alba Pérez, Dolores Subira, Jaime Arbeteta, Sonia Herrero, Dolores Morales (abstract)
PB2238 – Efficacy And Safety Of Treatment With Bortezomib, Cyclophosphamide, Cexamethasone (VCD) Versus Bortezomib, Dexamethasone (VD) Regimens In Newly Diagnosed Patients With Multiple Myeloma (NDMM)
Ma Liangming (abstract)
PB2239 – The Autophagy Inhibitor Hydroxychloroquine Added To Thalidomide Based Therapy For Multiple Myeloma Deepens Response And Prolongs Remission In Patients Previously Treated With Thalidomide
Stephen O'mara (abstract)
PB2240 – CT And MRI May Result In Overdiagnosis Of Skeletal Disease In Multiple Myeloma
Anders Erik Astrup Dahm, Viktor Dalen, Anne-Sofie Vegsgaard Olsen, Claude-Pierre Jerome, Jonn-Terje Geitung (abstract)
PB2241 – Bortezomib Induction And Maintenance Therapy In Multiple Myeloma Patients Ineligible For Transplantation
Kameliya Milcheva, Doroteya Todorieva, Ivan Kindekov, Emilia Naseva, Branimir Spasov (abstract)
PB2242 – Incidence And Prevalence Of Multiple Myeloma In A Large Nationwide Health Plan In Israel
Clara Weil, Shulamit Gelerstein, Gabriel Chodick, Sarah Sharman Moser, Nava Barit Ben-David, Varda Shalev, Dina Meytes (abstract)
PB2243 – Bortezomib, Lenalidomide And Dexamethasone In The Management Of Relapsed And Refractory Multiple Myeloma: A Real-Life Experience
Claudio Cerchione, Anna Emanuele Pareto, Irene Zacheo, Maria Di Perna, Davide Nappi, Ilaria Peluso, Katia Ferrara, Alessandra Romano, Fabrizio Pane, Lucio Catalano (abstract)
PB2244 – Outcome Of Patients With Multiple Myeloma And Renal Failure In Era Of Novel Agents – Experience Of A Tertiary Care Centre From Northern India
Nitin Gupta, Faran Naim, Ambar Garg, Kartik Purohit, Mythili Mulam (abstract)
PB2245 – Young Adults With Multiple Myeloma – Unveiling A Different Spectrum In A Resource Constrained Setting
Sumeet Mirgh, Manoranjan Mahapatra, Tulika Seth, Renu Saxena, Hara Prasad Pati, Seema Tyagi, Mukul Aggarwal, Rishi Dhawan, Rohan Halder, Sweta Kothari, Richa Chauhan (abstract)
PB2246 – Non-Myeloma Kidney Disease And Management Algorithm In Myeloma Patients
Katy Westwood, Shiva Natarajan, Sumaya Elhanash, Ibraham Ali, Simon Watt (abstract)
PB2247 – The Myeloma Canada Research Network Canadian Multiple Myeloma Database (MCRN CMM-DB): Multi-Institutional Sharing Of Clinical Data For Research
Christopher P Venner, Esther Masih-Kahn, Tran Truaon, Victor Jimenez-Zepeda, Arleigh McCurdy, Micahel Sebag, Kevin Song, Tony Reiman, Richard LeBlanc, Julie Stakiw, Martha Louzada, Rami Kotb, Darrell White, Muhammad Aslam, Aldo Del Col, Sofia Tavoularis, Engin Gul, Donna Reece (abstract)
PB2248 – Bulky Extramedullary Soft-Tissue Plasmacytomas In Newly Diagnosed Multiple Myeloma Patients: A Single-Center Experience From North India
Uttam Nath, Rituparna Chetia, Jayanta Nanda, Avriti Baveja (abstract)
PB2249 – Pomalidomide-Dexamethasone In The Management Of Heavily Pretreated Multiple Myeloma
Claudio Cerchione, Davide Nappi, Anna Emanuele Pareto, Ilaria Migliaccio, Irene Zacheo, Maria Di Perna, Ilaria Peluso, Katia Ferrara, Alessandra Romano, Fabrizio Pane, Lucio Catalano (abstract)
PB2250 – Prognostic Significance Of Heavy / Light Chain Ratio In Intact Immunoglobulin Multiple Myeloma Patients –Preliminary Results
Ioannis Kakkas, Ioannis Konstantellos, Sosana Delimbasi, Katerina Papageorgiou, Nikolaos Harhalakis, Alexandra Tsirogianni (abstract)
PB2251 – Response To Induction Therapy In Multiple Myeloma Patients; A Single Centre Experience
Munira Borhany, Muhammad Afzal, Abdul Hayee, Uzma Zaidi, Tahir Shamsi (abstract)
PB2252 – Addressing Unmet Medical Needs In Maintenance Treatment For Newly Diagnosed Multiple Myeloma (NDMM): Current Treatment Landscape And Emerging Therapeutic Options
Wee Joo Chng, Meral Beksac, Roman Hajek, Katja Weisel, Maria-Victoria Mateos, Andrew Spencer, Shinsuke Iida, Danielle de Farias, Richard Labotka, Tomas Skacel, Antonio Palumbo, Sagar Lonial, Shaji Kumar, Meletios Dimopoulos (abstract)
PB2253 – Possible Factors Of Progression In Monoclonal Gammopathy In Patients Of Gomel Region In Belarus
Zhanna Kozich, Victor Martinkov, Zhanna Pugacheva, Luidmila Smirnova (abstract)
PB2254 – Daratumumab-Ixazomib-Dexamethasone: A New Therapeutic Regimen For Relapsed Multiple Myeloma?
Silvia Martín-Batista, Melania Moreno-Vega, Patricia Hernández-Hernández, Alejandro Martín-Martín, Patricia Machado-Machado, Sunil Lakwhani, Carolina De Bonis-Braun, Bernardo González-González, Maria José Rodriguez-Salazar, Beatriz Soria-Santabárbara, Sandra Iraheta-Reyes, Taida Martín-Santos, Maria Remedios Arcas-Vega, Karan Mayani, José María Raya, Miguel T Hernández (abstract)
Quality of Life, Palliative Care, Ethics and Health Economics
PB2374 – Time From Symptom Onset To Diagnosis And Treatment Among Hematological Malignancies: Disease, Patient And Health System Related Influencing Factors
Austėja Dapkevičiūtė, Laimonas Griškevičius, Virginijus Šapoka, Elena Martynova, Valdas Pečeliūnas (abstract)
PB2383 – Real‐World Utilization Of Multiple Myeloma Treatments In The Era Of Novel Therapies: What Is The Current Standard Of Care?
David Singer, Ellen Thiel, Debra Irwin, Meghan Moynihan, Caroline McKay, Eric Maiese (abstract)
PB2392 – A 4-year Experience In Palliative Care Of The Onco-Hematology Patient
Maria Couto, Isabel Oliveira, Nelson Domingues, Mário Mariz, José Ferraz-Gonçalves (abstract)
PB2400 – Tertiary Prevention For Patients With Multiple Myeloma
Pavel Kotoucek, Roumen Bezergianov, Robert Enright, Waseem Nagi, Zuzana Ondrusova, Alberto Orfao, Zdenka Stefanikova, Jan Sedlak (abstract)
Stem Cell Transplantation – Clinical
PB2426 – Cytarabine Is More Effective Than Cyclophosphamide As A Stem Cell Mobilization Regimen In Multiple Myeloma
Lucie Adamusová, Tomáš Jelínek, Michal Šimíček, Milan Navrátil, Michal Kaščák, Hana Plonková, Jana Mihályová, Juraj Ďuraš, Ivana Tvrdá, Zdeněk Kořístek, Roman Hájek (abstract)
PB2433 – The Use Of The Anti-Emetic Akynzeo For Autologous Stem Cell Transplant Patients Receiving High Dose Melphalan : Results Of Pilot Study Show Reduction In Emesis, Nausea And Length Of Hospital Stay
Rachel Hall, Rebecca Brooks, Lisa Hammond, Roger Hudson (abstract)
PB2440 – In Multiple Myeloma, After CTX-Based PBSC Mobilization, The Use Of High Dose G-CSF (10 mcg/kg) Is More Effective In Respect To Low Dose G-CSF (5 mcg/kg) But Only If Plerixafor On Demand Is Not Used
Salvatore Leotta, Alessandra Cupri, Andrea Spadaro, Giuseppe Sapienza, Luca Scalise, Maria Grazia Michieli, Giuseppe Milone (abstract)
PB2455 – Relationship Between The Content Of CD34 + Cells And Their Colony-Forming Capacity In Patients With Multiple Myeloma In The Process Of Preparing A Leukaperesis Product For Autologous Transplantation
Jeanna Chubukina, Valentina Balashova, Victor Rugal, Natalya Semenova, Ivan Kostroma, Sergey Gritsaev, Tatiana Glazanova, Ludmila Bubnova, Sergey Voloshin, Stanislav Bessmeltsev (abstract)
PB2462 – Could The Outpatient-Based Autologous Stem Cell Transplantation Reduce The “Financial Toxicity” Without Adversely Affecting The Effectiveness And Safety Of The Method?
Panayotis Kaloyannidis, Eshrak Shaibani, Nihad Al Mokhtar, Fuad Aburahman, Enas Mutahar, Mohamed Al Darweesh, Omar Abduljalil, Ann Estanislao, Bacal Jenifer, Reem Khalili, John Apostolidis, Khalid Al Anezi, Hani Al Hashmi (abstract)
PB2463 – Autologous Hematopoietic Cell Transplantation For Lymphoid Malignancies In Patients Of 65 Years Old And Beyond. A Single Center Feasibility Experience
Stéphanie Desilets, Emmanuelle Nicolas-Virelizier, Fabien Subtil, Lila Gilis, Laure Lebras, Souad Assaad, Yann Guillermin, Philippe Rey, Mauricette Michallet, Amine Belhabri, Anne-Sophie Michallet (abstract)
PB2467 – Comparison Of Peripheral Stem Cell Mobilization Of Patients With Multiple Myeloma And Lymphoma In Late Middle Age (55-64 Years) Versus Old Age (older Than 65 Years): A Single Center Experience
Zafer Gulbas, demet çekdemir, imran dora, çiğdem eren (abstract)
PB2470 – A Study Of Upfront Autograft Following 3 To 4 Cycles Of Bortezomib, Lenalidomide And Dexamethasone Based Chemotherapy In 52 Indian Myeloma Patients – A Tertiary Centre Experience From Chennai, India
Kishore Kumar, chezhian subash (abstract)
PB2476 – Autologous Stem-Cell Transplantation As First-line Treatment Of Elderly Patients With A Newly Diagnosed Multiple Myeloma In The Era Of The Novel Drugs
Valentin Cabanas Perianes, Maria Moya, Begoña Navarro, Maria Jose Moreno, Amelia Martinez Marin, Elena Fernandez Poveda, Mercedes Berenguer, Juan Jose Cerezo, Raul Perez Lopez, Andres Sanchez Salinas, Ana Maria Garcia Hernandez, Jorge Monserrat, Miguel Blanquer, Jose Maria Moraleda (abstract)
PB2477 – Influence Of Lenalidomide Used In Induction Period And Intensity Of Mobilization Regimen On The Number Of CD34+ Cells Harvested In Patients With Multiple Myeloma
Ivan Kostroma, Ananstasiya Zhernaykova, Zhana Chubukina, Irina Zapreeva, Natalya Semenova, Stanislav Bessmeltsev, Alexander Chechetkin, Sergey Gritsaev (abstract)
PB2480 – The Role Of Myeloid-Derived Suppressor Cells In Autologous Hematopoietic Stem Cell Transplantation
Anika Betsch, Omer Rutgeerts, Sabine Fevery, Ben Sprangers, Daan Dierickx, Mariëlle Beckers (abstract)
PB2482 – The Role Of Autologous Stem-Cell Transplantation In Relapsed Multiple Myeloma. Our Six Year Experience.
Begoña Navarro Almenzar, Valentin Cabañas Perianes, Miguel Blanquer Blanquer, María José Moreno Belmonte, Juan José Cerezo Manchado, Raul Pérez López, Mercedes Berenguer-Piqueras1, Francesca Labbadia, Elena Fernández Poveda, Amelia Martínez Marín, María Moya Arnao, José María Moraleda Jiménez (abstract)
Transfusion Medicine
PB2526 – Daratumumab And Blood-Compatibility Testing: Experience In Our Center
Estefania Morente Constantin, Pablo Romero Garcia, Maria Pilar Garrido Collado, Almudena Garcia Ruiz, Esther Clavero Sanchez, Mamnuel Jurado Chacon, Rafael Rios Tamayo (abstract)
PB2532 – Frequency Of Anemia In Lymphoproliferative Disorders Patients During Antitumor Therapy
Nikolay Romanenko, Nadegda Potikhonova, Alexander Chechetkin, Sergey Voloshin, Stanislav Bessmeltsev (abstract)
